CHIH


MSCI China Health Care ETF

Reasons to Consider CHIH

Targeted Exposure

CHIH is a targeted play on the Health Care Sector in China – the world’s second largest economy by GDP.

ETF Efficiency

In a single trade, CHIH delivers access to dozens of health care companies within the MSCI China Index, providing investors an efficient vehicle to express a sector view on China.

All Share Exposure

The Index incorporates all eligible securities as per MSCI’s Global Investable Market Index Methodology, including China A, B and H shares, Red chips, P chips and foreign listings, among others.

Key Information As of 11/28/22

Inception Date 12/07/18
Total Expense Ratio 0.65%
Net Assets $9.10 million
NAV $15.17
Fact Sheet

ETF Summary

The Global X MSCI China Health Care ETF (CHIH) seeks to invest in large- and mid-capitalization segments of the MSCI China Index that are classified in the Health Care Sector as per the Global Industry Classification System (GICS).

ETF Objective

The Global X MSCI China Health Care ETF (CHIH) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index.

Trading Details As of 11/28/22

Ticker CHIH
Bloomberg Index Ticker NU722071
CUSIP 37954Y541
ISIN US37954Y5419
Primary Exchange NYSE Arca
Shares Outstanding 600,002
Number of Holdings 83
30-Day Median Bid-Ask Spread 1.35%

Distributions As of 11/28/22

30-Day SEC Yield 0.66%
Distribution Frequency Semi-Annually

ETF Prices As of 11/28/22

NAV $15.17 Daily Change $0.02 0.13%
Market Price $15.34 Daily Change $0.34 2.27%

Performance History

As of recent
(09/30/22)
As of recent
(09/30/22)
Fund NAV Market Price Index
1 Year -49.52% -49.95% -49.23%
3 Years -4.97% -5.13% -4.29%
Since Inception -2.69% -2.89% -2.01%
1 Year -45.67% -45.76% -45.33%
3 Years -8.47% -8.38% -7.82%
Since Inception -2.49% -2.64% -1.80%
Year-to-Date -38.29% -38.63% -38.02%
1 Month -15.48% -15.79% -15.46%
3 Months -22.93% -24.24% -22.85%
Since Inception -9.90% -10.57% -7.46%
Year-to-Date -37.92% -38.17% -37.60%
1 Month 0.60% 0.75% 0.69%
3 Months -18.52% -18.06% -18.41%
Since Inception -9.36% -9.90% -6.82%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 11/28/22

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
9.88 1093 HK CSPC PHARMACEUTI 6191997 1.23 728,808 899,578.82
8.46 2269 HK WUXI BIOLOGICS CAYMAN INC BL6B9P1 6.06 127,180 770,260.42
7.29 BGNE BEIGENE LTD-ADR BYYWPW6 179.29 3,703 663,910.87
5.23 1177 HK SINO BIOPHARMACEUTICAL B00XSF9 0.55 861,300 475,923.31
3.54 1801 HK INNOVENT BIOLOGICS INC BGR6KX5 3.69 87,400 322,519.54
3.28 1066 HK SHANDONG WEIG-H 6742340 1.41 212,100 298,422.89
2.90 300760 C2 SHENZHEN MINDR-A BHQK864 45.07 5,861 264,129.45
2.86 1099 HK SINOPHARM GROUP CO-H B3ZVDV0 2.22 117,300 260,463.28
2.85 2359 HK WUXI APPTEC CO LTD-H BGHH0L6 9.20 28,156 258,939.69
2.64 1548 HK GENSCRIPT BIOTECH CORP BD9Q2J2 2.38 100,996 240,279.04
2.34 ZLAB ZAI LAB LTD-ADR BD9GVY0 31.05 6,857 212,909.85
2.14 3692 HK HANSOH PHARMACEU BJYKB72 1.81 107,300 194,614.29
2.06 600276 C1 JIANGSU HENGRU-A BP3R369 5.42 34,672 187,789.29
2.04 LEGN LEGEND BIOTECH CORP-ADR BMX9K07 48.15 3,852 185,473.80
1.75 867 HK CHINA MEDICAL SY B6WY993 1.25 126,900 159,069.34
1.68 1530 HK 3SBIO INC BY9D3L9 1.04 146,700 152,927.82
1.65 6078 HK HYGEIA HEALTHCAR BMX09H0 5.58 27,000 150,573.67
1.62 2196 HK FOSUN PHARMA-H B8XBQ96 3.11 47,300 147,016.54
1.57 603259 C1 WUXI APPTEC CO LTD-A BHWLWV4 10.52 13,624 143,266.80
1.54 300015 C2 AIER EYE HSPTL-A BD5CLQ4 3.59 39,048 140,345.87
1.42 570 HK TRAD CHI MED 6971779 0.47 276,600 129,134.96
1.37 853 HK MICROPORT SCIENTIFIC CORP B676TW7 2.15 58,100 124,700.12
1.35 2607 HK SHANGHAI PHARM-H B4Q4CJ6 1.57 78,600 123,257.06
1.33 600436 C1 ZHANGZHOU PIEN-A BP3R7Z6 34.41 3,506 120,647.03
1.19 300122 C2 CHONGQING ZHIF-A BD5CJY8 12.35 8,733 107,866.23
1.09 HCM HUTCHMED CHINA-ADR BYXV9H7 11.89 8,357 99,364.73
1.08 6185 HK CANSINO BIOLOGICS INC-H BJKDJS2 12.47 7,900 98,521.38
1.00 000538 C2 YUNNAN BAIYAO-A BD5CP95 7.75 11,714 90,746.70
0.99 3347 HK HANGZHOU TIGER-H BMZC7F8 8.86 10,120 89,639.43
0.95 1951 HK JINXIN FERTILITY BJ9JY53 0.70 123,200 86,355.51
0.95 3759 HK PHARMARON BEIJ-H BK72QD3 5.32 16,175 86,066.95
0.75 000963 C2 HUADONG MEDICINE CO LTD-A BD5CM94 5.59 12,211 68,297.47
0.74 002603 C2 SHIJIAZHUANG Y-A BD5CHJ9 6.10 11,027 67,223.86
0.73 600196 C1 SHANGHAI FOSUN-A BP3R3M5 4.90 13,574 66,576.19
0.70 603392 C1 BEIJING WANTAI-A BMXTWX4 20.46 3,090 63,219.01
0.67 300896 C2 IMEIK TECHNOLO-A BNR4MY3 63.30 956 60,510.06
0.63 300142 C2 WALVAX BIOTECHNOLOGY CO-A BD5CG36 6.00 9,600 57,608.76
0.58 000661 C2 CHANGCHUN HIGH-A BD5CDB3 22.73 2,328 52,913.33
0.58 002001 C2 ZHEJIANG NHU CO LTD-A BD5CH66 2.71 19,368 52,557.24
0.57 600332 C1 GUANGZHOU BAIY-A BP3R4Q6 3.99 13,059 52,135.63
0.54 002294 C2 SHENZHEN SALUBRIS PHARM-A BD5CM05 4.78 10,200 48,786.96
0.52 600085 C1 BEIJING TONGRENTANG CO-A BP3R5C9 6.52 7,200 46,958.90
0.51 300759 C2 PHARMARON BEIJ-A BK4XYC4 8.95 5,200 46,551.93
0.50 300347 C2 HANGZHOU TIGER-A BD5CCK5 12.29 3,716 45,651.85
0.48 002422 C2 SICHUAN KELUN-A BD5CL08 3.23 13,600 43,955.27
0.47 000999 C2 CHINA RESOURCE-A BD5CL42 7.63 5,600 42,732.14
0.47 601607 C1 SHANG PHARM -A BP3R4Z5 2.57 16,500 42,402.44
0.43 603858 C1 SHANDONG BUCHA-A BYW5NC3 3.00 13,087 39,312.20
0.43 600998 C1 JOINTOWN PHARMACEUTICAL-A BP3R541 1.84 21,270 39,106.29
0.42 000423 C2 DONG-E-E-JIAOCO LTD-A BD5CM61 5.36 7,200 38,598.27
0.39 300003 C2 LEPU MEDICAL TECHNOLOGY-A BD5CM16 3.10 11,501 35,613.21
0.38 688180 C1 SHANGHAI JUNSH-A BLCD7F7 8.77 3,960 34,733.96
0.37 002821 C2 ASYMCHEM LABOR-A BD6V5C4 18.47 1,838 33,945.29
0.37 600763 C1 TOPCHOICE MEDI-A BYYFJH8 16.99 1,980 33,630.90
0.35 002007 C2 HUALAN BIOLOGI-A BD5CL19 2.76 11,670 32,248.62
0.35 300832 C2 SHENZHEN NEW-A BMXTX20 6.72 4,800 32,241.53
0.34 300601 C2 SHENZHEN KANGT-A BFY8HT2 4.70 6,548 30,776.21
0.33 002223 C2 JIANGSU YUYUE-A BD5CJM6 4.83 6,300 30,420.52
0.33 600161 C1 BEIJING TIAN-A BP3R9J4 3.00 10,080 30,251.57
0.32 002252 C2 SHANGHAI RAAS -A BD5CPJ5 0.75 39,100 29,295.68
0.32 002044 C2 MEINIAN ONEHEA-A BD73L10 0.71 41,020 28,976.38
0.31 600079 C1 HUMANWELL HEAL-A BP3R712 2.89 9,800 28,313.91
0.31 603456 C1 ZHEJIANG JIUZH-A BMQBVL8 5.57 5,000 27,854.96
0.29 603882 C1 GUANGZHOU KING-A BFYX689 9.55 2,800 26,746.29
0.29 688363 C1 BLOOMAGE BIOTE-A BP91NT8 14.68 1,801 26,442.75
0.28 600521 C1 ZHEJIANG HUAHA-A BP3RBR6 2.79 9,210 25,705.35
0.27 688185 C1 CANSINO BIOLOGICS INC-A BMD9JD3 29.58 830 24,553.84
0.26 603707 C1 NANJING KING-F-A BF2DZL7 2.39 10,036 23,945.78
0.26 300357 C2 ZHEJIANG WOLWO-A BFY8GY0 6.93 3,423 23,730.42
0.25 000739 C2 APELOA PHARMA-A BD5LY17 2.88 8,000 23,047.04
0.25 000513 C2 LIVZON PHARM-A BD5CQ25 5.13 4,400 22,559.89
0.24 600380 C1 JOINCARE PHARM-A BP3RBV0 1.67 13,100 21,912.11
0.24 002030 C2 DAAN GENE CO LTD-A BD5CKW3 2.37 9,160 21,741.69
0.23 603127 C1 JOINN LABORATO-A BK94819 7.98 2,640 21,064.82
0.23 300676 C2 BGI GENOMICS CO LTD-A BFY8H58 7.98 2,633 21,008.97
0.23 300595 C2 OVCTEK CHINA INC-A BHQPSJ2 4.18 5,024 20,988.03
0.22 300529 C2 JAFRON BIOMEDI-A BFY8H03 4.34 4,700 20,375.18
0.22 300558 C2 BETTA PHARMACE-A BD6QWL7 6.95 2,920 20,303.85
0.21 300253 C2 WINNING HEALTH-A BD5CKZ6 1.22 15,870 19,349.65
0.19 688298 C1 ZHEJIANG ORIEN-A BNR4NX9 14.55 1,211 17,624.53
0.19 300677 C2 INTCO MEDICAL-A BMTCVT6 3.27 5,140 16,804.35
0.18 688202 C1 SHANGHAI MEDICILON INC-A BNR4NV7 30.07 547 16,446.52
0.13 600056 C1 CHINA MEHECO CO LTD -A BP3R8X1 2.26 5,300 11,957.04
0.08 CASH 1.00 7,625 7,625.89
Holdings are subject to change.

ETF Characteristics As of 11/28/22

Return on Equity 7.70%
Weighted Avg. Market Cap 10,999 M
2021 2022
Price-to-earnings 38.18 41.54
Price-to-book value 3.29 3.14

Source: AltaVista Research, LLC

ETF Risk Stats As of 10/31/22

Versus Beta
S&P 500 0.34
MSCI EAFE 0.39
MSCI Emg. Mkts 0.77
Standard Deviation 28.60%

Source: AltaVista Research, LLC

ETF Research

View More Related Research

Investing involves risk, including the possible loss of principal. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Securities focusing on a single country and narrowly focused investments may be subject to higher volatility. CHIH is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by MSCI, nor does MSCI make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with MSCI.

Back to Top